Section Arrow
SRZN.NASDAQ
- Surrozen
Quotes are at least 15-min delayed:2026/10/28 05:24 EDT
Pre Market
Last
 29.52
-0.01 (-0.03%)
Bid
22
Ask
--
High 29.52 
Low 29.52 
Volume 14 
Regular Hours (Closed)
Last
 29.53
+2.25 (+8.25%)
Day High 
30.35 
Prev. Close
27.28 
1-M High
33.38 
Volume 
431.58K 
Bid
22
Ask
--
Day Low
27.28 
Open
27.38 
1-M Low
21.85 
Market Cap 
320.64M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 24.86 
20-SMA 26.76 
50-SMA 23.85 
52-W High 37.83 
52-W Low 11.39 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-40.06/-5.01
Enterprise Value
325.99M
Balance Sheet
Book Value Per Share
-18.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.48M
Operating Revenue Per Share
1.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SNTISenti Biosciences Holdings Inc.0.1867+0.0116+6.62%-- 
Pre Market 0.1874 +0.0007 +0.37%
RXRXRecursion Pharmaceuticals4.05+0.25+6.58%-- 
Pre Market 4.02 -0.03 -0.74%
NAUTNautilus Biotechnolgy2.89+0.45+18.44%-- 
Pre Market 2.8602 -0.0298 -1.03%
MRNAModerna207.97+9.12+4.59%-- 
Pre Market 204.99 -2.98 -1.43%
SXTP60 Degrees Pharmaceuticals Inc.0.74-0.1279-14.74%-- 
Pre Market 0.7001 -0.0399 -5.39%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.